Search

Displaying results 4271 - 4280 of 5449 in total
  1. Drug

    Mipomersen

    go.drugbank.com/drugs/DB05528
    Approved

    It is marketed under the brand name Kynamro in the United States, and the FDA label includes a black box warning of hepatoxicity.

  2. Drug

    Desmoteplase

    go.drugbank.com/drugs/DB04925
    Investigational

    When a vampire bat bites its victim, it secretes an enzyme that prevents the blood from clotting. … It activates plasminogen to the serine protease, plasmin. Plasmin acts by breaking down fibrin blood clots.

  3. Drug

    AZD 3355

    go.drugbank.com/drugs/DB05404
    Investigational

    It is developed by AstraZeneca and is currently in phase I/II trials.

  4. Drug

    Asvasiran

    go.drugbank.com/drugs/DB05638
    Investigational

    It has the potential to treat or prevent RSV infection.

  5. Drug

    Dimethylcurcumin

    go.drugbank.com/drugs/DB06133
    Investigational

    It is a novel anti-androgen that enhances androgen receptor degradation.

  6. Drug

    Cythioate

    go.drugbank.com/drugs/DB11392
    ExperimentalVet approved

    It is mainly used in veterinary as a treatment for fleas.

  7. Drug

    AEM-28

    go.drugbank.com/drugs/DB17642
    Investigational

    AEM-28 is a 28 amino acid mimetic of apolipoprotein E being investigated for lipid disorders, such as homozygous familial hypercholesterolemia. It possesses anti-inflammatory properties.[A258764]

  8. Drug

    Reloxiliase

    go.drugbank.com/drugs/DB17653
    Experimental

    It is being investigated for the treatment of hyperoxaluria.[A258823]

  9. Drug

    WP-1301

    go.drugbank.com/drugs/DB17702
    Experimental

    It binds to an MHC class II molecule and is recognized by a Factor VIII-specific T cell.[L46138]

  10. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    It is under investigation for the treatment of growth hormone deficiency.